ArticleThe Indian journal of medical research2026
Molecular, serological, and epidemiological characterisation of a hepatitis A virus outbreak in Maharashtra, India, 2025.
Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Hepatitis A virus (HAV) remains a major cause of jaundice outbreaks globally, with 158.9 million infections reported in 2019 despite a 63% decline in mortality since 1990. Improved sanitation in many regions has shifted the age of primary infection from early childhood to older children and adults, increasing the risk of symptomatic and severe disease. In April-May 2025, we investigated an outbreak of HAV caused hepatitis that occurred in Rajur village, Ahilyanagar district, Maharashtra. A total of 327 suspected cases of acute hepatitis were reported, mainly affecting older children and young adults. Methods Suspected acute hepatitis cases were identified by clinical presentation and their epidemiological and clinical data were collected by questionnaire. Serum, stool, and potable water samples were collected and tested by anti-HAV IgM ELISA and/or real-time RT-PCR to confirm outbreak aetiology. Full HAV genome sequences were obtained from selected RT-PCR positive specimens. Results The age-specific attack rate for the 327 acute hepatitis cases was the highest in children aged 10-19 years (11.97%) and lowest in those ≥ 50 years. Anti-HAV IgM antibodies were detected in 32 of 45 (71.1%) available serum samples, and HAV RNA was detected in 7 of 22 (31.8%) serum and 19 of 31 (61.3%) stool samples tested. All 7 potable water samples tested negative for HAV RNA. Genomic analysis revealed strain details relevant to disease severity, providing insights into circulating HAV lineages in India. Interpretation and conclusions The findings highlight the need for continuous surveillance, genomic monitoring, and targeted prevention strategies to protect vulnerable, previously unexposed populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.